Valuation: Virbac

Market Cap 2.79B 3.18B 2.57B 2.4B 4.52B 301B 4.6B 30.84B 11.97B 148B 11.96B 11.69B 517B P/E 2026 *
16.6x
P/E 2027 * 14.7x
Enterprise Value 2.91B 3.32B 2.68B 2.5B 4.72B 314B 4.8B 32.18B 12.49B 155B 12.48B 12.2B 540B EV / Sales 2026 *
1.88x
EV / Sales 2027 * 1.72x
Free-Float
49.03%
Yield 2026 *
0.52%
Yield 2027 * 0.62%
1 week-0.90%
1 month-7.52%
3 months-5.41%
6 months-6.74%
Current year-6.74%
1 week 330
Extreme 330
346
1 month 329
Extreme 329
360
3 years 241
Extreme 241
400
5 years 216.5
Extreme 216.5
446.5
Manager TitleAgeSince
Chief Executive Officer 46 01/09/2025
Chief Executive Officer 50 27/09/2024
Chief Operating Officer 64 01/01/2022
Director TitleAgeSince
Chairman 61 01/04/2006
Director/Board Member 68 28/07/2010
Director/Board Member 65 05/09/2017
Change 5-day change 1-year change 3-year change Capi.($)
-0.60%+0.44%+4.24%+22.96% 3.18B
-1.90%-6.48%-53.92%-58.27% 30.13B
-0.53%+6.17%+72.34%+144.63% 12.29B
-1.26%-16.76%-18.65%-1.51% 3.56B
-1.69%-1.94%+45.26%+22.50% 1.87B
-2.14%-4.17%-27.91%+12.30% 1.59B
-1.29%+2.85%+22.94%+129.20% 1.27B
-2.89%-6.72%-25.70%-18.93% 965M
-0.03%-.--%-.--%+104.22% 919M
-2.80%-7.09%-19.51%-49.49% 887M
Average -1.61%-3.16%-0.09%+30.76% 5.94B
Weighted average by Cap. -1.53%-3.57%-13.42%+6.18%

Financials

2026 *2027 *
Net sales 1.55B 1.77B 1.43B 1.33B 2.51B 167B 2.55B 17.12B 6.65B 82.43B 6.64B 6.49B 287B 1.64B 1.87B 1.51B 1.41B 2.66B 177B 2.71B 18.15B 7.05B 87.39B 7.04B 6.88B 304B
Net income 167M 191M 154M 144M 271M 18.04B 276M 1.85B 718M 8.9B 717M 701M 31.02B 190M 217M 176M 164M 309M 20.55B 314M 2.11B 818M 10.14B 816M 798M 35.32B
Net Debt 121M 138M 112M 104M 196M 13.07B 200M 1.34B 520M 6.45B 519M 508M 22.47B 26.49M 30.27M 24.46M 22.81M 42.98M 2.86B 43.75M 293M 114M 1.41B 114M 111M 4.92B
Logo Virbac
Virbac specializes in the research, production and marketing of veterinary medicines. Net sales break down by family of products as follows: - pet medications (60.7%): pest control drugs, vaccines, antibiotics, anesthetics, anti-inflammatory drugs, mouth/dental care products, ophthalmologic and dermatological products intended for dogs, cats, horses, birds, rodents, etc. The group also offers foods and electronic identification chips; - livestock medications (39.3%): pest control drugs and antibiotics intended for cattle, sheep, pigs, poultry, etc. Net sales are distributed geographically as follows: Europe (41.6%), Latin America (15.2%), North America (13.6%), India/Africa/Middle East (12.2%), Eastern Asia (10.5%) and Pacific (6.9%).
Employees
-
Date Price Change
01/07/26 330.00 -0.60%
30/06/26 €332.00 -2.35%
29/06/26 €340.00 -0.58%
26/06/26 €342.00 -0.15%
25/06/26 €342.50 +0.74%
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
332.50EUR
Average target price
412.88EUR
Spread / Average Target
+24.17%

Quarterly revenue - Rate of surprise